C/A 0001139685 XXXXXXXX 020-30706 LIVE false false false true Issuer is extending campaign end date 20/20 GeneSystems, Inc. Corporation DE 08-07-2000 15810 GAITHER ROAD, SUITE 235 GAITHERSBURG MD 20877 https://2020gene.com/ N StartEngine Capital, LLC 0001665160 007-00007 Up to 9% percent We charge 3% commission paid in equity or securities at the same rate as this offering. Other Convertible Note 9995 N/A 9995.40 Y Other At issuer's discretion, with priority given to StartEngine Owners 4999995.00 12-15-2022 45.00 10272281.00 4677734.00 3354469.00 3468192.00 4215465.00 205071.00 0.00 103860.00 0.00 40247.00 9622332.00 2330528.00 4927374.00 1453354.00 0.00 0.00 2071777.00 -2021826.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY 20/20 GeneSystems, Inc. Jonathan Cohen CEO, President Jonathan Cohen CEO, President 11-14-2022 Anne Shiflett Director of Finance 11-14-2022 Richard Cohen Director 11-14-2022 John Rollins Director 11-14-2022 Michael A Ross Director 11-14-2022